Michal Doležal

411 citations
14 papers · 236 indexed · h-index 7

Michal Doležal

14 papers receiving 236 citations

Peers

Michal Doležal
Comparison fields: 5 of 46
  • Virology 83
  • Structural Biology 12
  • Infectious Diseases 61
  • Epidemiology 66
  • Hepatology 15
Replace Christopher Fillmore with:
Christopher Fillmore United States
Bartek Nogal United States
João I. Mamede United States
Maria Anders‐Össwein Germany
Maria Anders Germany
Leigh M. Sewall United States
Yasuyuki Miyazaki Japan
Matthew R. England United States
Sanela Rankovic Israel
K. M. Rifat Faysal United States
Michal Doležal relative to Christopher Fillmore United States Christopher Fillmore's profile →
Citations per field
00.5×3.9×
Christopher Fillmore · 1×
Citations per year

Countries citing papers authored by Michal Doležal

Since Specialization
Citations

This map shows the geographic impact of Michal Doležal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Doležal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Doležal more than expected).

Fields of papers citing papers by Michal Doležal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Doležal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Doležal. The network helps show where Michal Doležal may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michal Doležal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michal Doležal Line = papers co-authored together Michal Doležal links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 20223
2 201935
3 201879
4 20168
5 20163
6 20166
7 20152
8 201440
9 20147
10 20141
11 20146
12 20133
13 201122
14 201121

About Michal Doležal

Michal Doležal is a scholar working on Virology, Infectious Diseases, Epidemiology, Hepatology and Molecular Biology, having authored 14 papers that have together received 236 indexed citations. Recurring topics across this work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (4 papers), Glycosylation and Glycoproteins Research (2 papers), Viral Infections and Immunology Research (2 papers), Protein Structure and Dynamics (2 papers), Virology and Viral Diseases (2 papers), Herpesvirus Infections and Treatments (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Virology (83 citations), Structural Biology (12 citations), Infectious Diseases (61 citations), Epidemiology (66 citations) and Hepatology (15 citations). Michal Doležal has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Michaela Rumlová, Tomáš Ruml, Iva Pichová, Romana Hadravová, John A. G. Briggs, F.K.M. Schur, Brice Murciano, Ivana Křížová, Alan Rein and Kun Qu. Their work appears in journals such as Retrovirology, Journal of Virology, Protein Expression and Purification, Journal of General Virology and FEBS Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026